Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (FY)Mar 31, 2023 | |
|---|---|---|---|
| Operating cash flow (Indirect Method) | |||
| Cash from operating activities | 44.61%1.28B | 54.43%886.1M | 573.77M |
| Net profit before non-cash adjustment | 12.87%526.7M | 83.83%466.64M | --253.84M |
| Total adjustment of non-cash items | 84.62%601.15M | -27.82%325.62M | --451.15M |
| -Depreciation and amortization | 11.67%342.28M | 24.76%306.51M | --245.68M |
| -Reversal of impairment losses recognized in profit and loss | 17.52%43.29M | -51.62%36.84M | --76.14M |
| -Disposal profit | 264.47%113.53M | -62.59%31.15M | --83.27M |
| -Net exchange gains and losses | ---- | -95.78%-21.36M | ---10.91M |
| -Other non-cash items | 470.81%102.04M | -148.31%-27.52M | --56.97M |
| Changes in working capital | 63.63%153.55M | 171.51%93.84M | ---131.22M |
| -Change in receivables | -60.40%17.43M | 127.24%44.01M | ---161.58M |
| -Change in inventory | 292.04%105.55M | 1,520.04%26.92M | ---1.9M |
| -Change in prepaid assets | --1.76M | ---- | ---- |
| -Change in payables | 130.22%3.36M | -159.55%-11.12M | --18.68M |
| -Change in accrued expense | 102.27%253K | -159.55%-11.12M | --18.68M |
| -Provision for loans, leases and other losses | 312.73%32.98M | -215.71%-15.5M | --13.4M |
| -Changes in other current assets | -115.70%-7.78M | 27,418.33%49.53M | --180K |
| Dividends paid (cash flow from operating activities) | |||
| Dividends received (cash flow from operating activities) | |||
| Interest paid (cash flow from operating activities) | -29.13%-28.62M | -10.25%-22.17M | -20.1M |
| Interest received (cash flow from operating activities) | 15.52%3.1M | 151.97%2.68M | 1.06M |
| Tax refund paid | 21.03%-55.4M | -860.90%-70.16M | -7.3M |
| Other operating cash inflow (outflow) | 16.30%-642.84M | -5.53%-768.05M | -727.8M |
| Operating cash flow | 1,863.05%557.62M | 115.75%28.41M | ---180.37M |
| Investing cash flow | |||
| Net PPE purchase and sale | -4,098.29%-58.82M | 80.02%-1.4M | ---7.01M |
| Repayment of advance payments to other parties and cash income from loans | --50.15M | ---- | ---- |
| Net changes in other investments | 560.35%24.97M | -291.56%-5.42M | --2.83M |
| Investing cash flow | 338.82%16.3M | -63.21%-6.82M | ---4.18M |
| Financing cash flow | |||
| Net issuance payments of debt | -1,147.50%-1.16B | -3.96%110.38M | --114.93M |
| Net common stock issuance | --1.68B | ---- | ---- |
| Issuance fees | ---14.51M | ---- | ---- |
| Net other fund-raising expenses | -100.00%-2K | ---1K | ---- |
| Financing cash flow | 360.11%507.85M | -3.96%110.38M | --114.93M |
| Net cash flow | |||
| Beginning cash position | 19.33%440.3M | -15.59%368.97M | --437.12M |
| Current changes in cash | 719.79%1.08B | 289.54%131.96M | ---69.62M |
| Effect of exchange rate changes | -100.17%-5K | 103.47%2.99M | --1.47M |
| Cash adjustments other than cash changes | 100.00%2K | --1K | ---- |
| End cash Position | 202.04%1.52B | 36.58%503.92M | --368.97M |
| Free cash flow | 1,747.09%498.81M | 114.41%27.01M | ---187.38M |
| Currency Unit | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |